Jun Chen

Corporate Officer/Principal presso VISEN Pharmaceuticals

54 anni

Health Technology

Profilo

Jun Chen is currently the Chief Commercial Officer at VISEN Pharmaceuticals since 2021.
Prior to this, he worked at Novo Nordisk China as the Vice President-Marketing from 2002 to 2016.

Posizioni attive di Jun Chen

Società	Posizione	Inizio
VISEN Pharmaceuticals VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China.	Corporate Officer/Principal	01/04/2021

Tutte le posizioni attive di Jun Chen

Precedenti posizioni note di Jun Chen

Società	Posizione	Fine
Novo Nordisk China Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders.	Vendite & Marketing	01/04/2016

Vedi nel dettaglio l'esperienza di Jun Chen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jun Chen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Novo Nordisk China Novo Nordisk China Medical SpecialtiesHealth Technology Part of Novo Nordisk Fonden, Novo Nordisk China is a Chinese global biopharmaceutical company headquartered in Copenhagen, Denmark. The company is based in Beijing, China. The company's goal is to drive change in order to overcome serious chronic diseases such as diabetes, obesity, rare blood diseases, and endocrine disorders.	Health Technology
VISEN Pharmaceuticals VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China.	Health Technology